{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:45:15Z","timestamp":1792633515499,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.clim.2024.110235","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T09:14:34Z","timestamp":1714986874000},"page":"110235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Targeted metabolomics combined with machine learning to identify and validate new biomarkers for early SLE diagnosis and disease activity"],"prefix":"10.1016","volume":"264","author":[{"given":"Jiabin","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeping","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangmei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10188","key":"10.1016\/j.clim.2024.110235_bb0005","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/S0140-6736(19)30546-X","article-title":"Novel paradigms in systemic lupus erythematosus","volume":"393","author":"D\u00f6rner","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.clim.2024.110235_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102531","article-title":"Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014","volume":"19","author":"Scherlinger","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.clim.2024.110235_bb0015","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.mayocp.2019.09.012","article-title":"Sex differences in systemic lupus erythematosus: epidemiology, clinical considerations, and disease pathogenesis","volume":"95","author":"Nusbaum","year":"2020","journal-title":"Mayo Clin. Proc."},{"issue":"9957","key":"10.1016\/j.clim.2024.110235_bb0020","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(14)60128-8","article-title":"Systemic lupus erythematosus","volume":"384","author":"Lisnevskaia","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.clim.2024.110235_bb0025","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/1049909119891999","article-title":"Trends of hospital palliative care utilization and its associated factors among patients with systemic lupus erythematosus in the United States from 2005 to 2014","volume":"37","author":"Yu","year":"2020","journal-title":"Am. J. Hosp. Palliat. Care"},{"issue":"4","key":"10.1016\/j.clim.2024.110235_bb0030","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/art.41577","article-title":"Hospitalized infections in lupus: a nationwide study of types of infections, time trends, health care utilization, and in-hospital mortality","volume":"73","author":"Singh","year":"2021","journal-title":"Arthritis Rheumatol."},{"issue":"12","key":"10.1016\/j.clim.2024.110235_bb0035","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/acr.24092","article-title":"Economic evaluation of damage accrual in an international systemic lupus erythematosus inception cohort using a multistate model approach","volume":"72","author":"Barber","year":"2020","journal-title":"Arthritis Care Res."},{"issue":"11","key":"10.1016\/j.clim.2024.110235_bb0040","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1177\/0961203317693096","article-title":"Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years","volume":"26","author":"Taraborelli","year":"2017","journal-title":"Lupus"},{"issue":"10188","key":"10.1016\/j.clim.2024.110235_bb0045","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/S0140-6736(19)30237-5","article-title":"Management strategies and future directions for systemic lupus erythematosus in adults","volume":"393","author":"Durcan","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clim.2024.110235_bb0050","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2020-218272","article-title":"Update \u03bfn the diagnosis and management of systemic lupus erythematosus","volume":"80","author":"Fanouriakis","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.clim.2024.110235_bb0055","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European league against rheumatism\/American college of rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol."},{"issue":"8","key":"10.1016\/j.clim.2024.110235_bb0060","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2024.110235_bb0065","doi-asserted-by":"crossref","first-page":"967371","DOI":"10.3389\/fimmu.2022.967371","article-title":"Metabolic profiling reveals new serum signatures to discriminate lupus nephritis from systemic lupus erythematosus","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2024.110235_bb0070","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3109\/14397595.2016.1158895","article-title":"Serum metabolomic profiling in patients with systemic lupus erythematosus by GC\/MS","volume":"26","author":"Yan","year":"2016","journal-title":"Mod. Rheumatol."},{"issue":"3","key":"10.1016\/j.clim.2024.110235_bb0075","first-page":"857","article-title":"Lipidomic and metabolomic profiling reveals novel candidate biomarkers in active systemic lupus erythematosus","volume":"12","author":"Li","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.clim.2024.110235_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.964901","article-title":"Absolute quantification and characterization of oxylipins in lupus nephritis and systemic lupus erythematosus","volume":"13","author":"He","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2024.110235_bb0085","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11306-017-1308-6","article-title":"Analysis of the free fatty acid metabolome in the plasma of patients with systemic lupus erythematosus and fever","volume":"14","author":"Shin","year":"2017","journal-title":"Metabolomics"},{"issue":"11","key":"10.1016\/j.clim.2024.110235_bb0090","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1177\/0961203317694256","article-title":"Metabolic profiling reveals new serum biomarkers of lupus nephritis","volume":"26","author":"Li","year":"2017","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.clim.2024.110235_bb0095","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/rheumatology\/keaa126","article-title":"Metabolomic profiling reveals serum L-pyroglutamic acid as a potential diagnostic biomarker for systemic lupus erythematosus","volume":"60","author":"Zhang","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.clim.2024.110235_bb0100","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13075-020-02264-2","article-title":"Caution in studying and interpreting the lupus metabolome","volume":"22","author":"Zhang","year":"2020","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.clim.2024.110235_bb0105","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/annrheumdis-2016-209519","article-title":"A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)","volume":"76","author":"van Vollenhoven","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2024.110235_bb0110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.aca.2015.02.012","article-title":"A tutorial review: metabolomics and partial least squares-discriminant analysis\u2013a marriage of convenience or a shotgun wedding","volume":"879","author":"Gromski","year":"2015","journal-title":"Anal. Chim. Acta"},{"issue":"1","key":"10.1016\/j.clim.2024.110235_bb0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1039\/C4MB00414K","article-title":"PLS\/OPLS models in metabolomics: the impact of permutation of dataset rows on the K-fold cross-validation quality parameters","volume":"11","author":"Triba","year":"2015","journal-title":"Mol. BioSyst."},{"issue":"5","key":"10.1016\/j.clim.2024.110235_bb0120","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/09612033231164635","article-title":"Mitochondrial bioenergetic changes in systemic lupus erythematosus immune cell subsets: contributions to pathogenesis and clinical applications","volume":"32","author":"Yennemadi","year":"2023","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.clim.2024.110235_bb0125","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1038\/s41467-021-22312-y","article-title":"Type I interferons affect the metabolic fitness of CD8 T cells from patients with systemic lupus erythematosus","volume":"12","author":"Buang","year":"2021","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.clim.2024.110235_bb0130","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1016\/j.cell.2021.07.021","article-title":"Erythroid mitochondrial retention triggers myeloid-dependent type I interferon in human SLE","volume":"184","author":"Caielli","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.clim.2024.110235_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109946","article-title":"Immunometabolomics provides a new perspective for studying systemic lupus erythematosus","volume":"118","author":"Wu","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.clim.2024.110235_bb0140","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3389\/fimmu.2019.00976","article-title":"Fecal metabolomics and potential biomarkers for systemic lupus erythematosus","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.clim.2024.110235_bb0145","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/bmc.3734","article-title":"Urinary metabolomic study of systemic lupus erythematosus based on gas chromatography\/mass spectrometry","volume":"30","author":"Yan","year":"2016","journal-title":"Biomed. Chromatogr."},{"issue":"7","key":"10.1016\/j.clim.2024.110235_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159384","article-title":"Metabolic profiling of systemic lupus erythematosus and comparison with primary Sj\u00f6gren\u2019s syndrome and systemic sclerosis","volume":"11","author":"Bengtsson","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2024.110235_bb0155","doi-asserted-by":"crossref","first-page":"35309","DOI":"10.1038\/srep35309","article-title":"NMR based serum metabolomics reveals a distinctive signature in patients with lupus nephritis","volume":"6","author":"Guleria","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.clim.2024.110235_bb0160","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12026-017-8960-9","article-title":"Increased lipid and protein oxidation and lowered antioxidant defenses in systemic lupus erythematosus are associated with severity of illness, autoimmunity, increased adhesion molecules, and Th1 and Th17 immune shift","volume":"66","author":"Scavuzzi","year":"2018","journal-title":"Immunol. Res."},{"issue":"1","key":"10.1016\/j.clim.2024.110235_bb0165","article-title":"Kynurenine pathway is altered in patients with SLE and associated with severe fatigue [published correction appears in Lupus Sci Med. 2019 May 17;6(1): e000254corr1]","volume":"5","author":"\u00c5kesson","year":"2018","journal-title":"Lupus Sci. Med."},{"issue":"5","key":"10.1016\/j.clim.2024.110235_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104241","article-title":"Microbiota-mediated skewing of tryptophan catabolism modulates CD4 T cells in lupus-prone mice","volume":"25","author":"Brown","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.clim.2024.110235_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102245","article-title":"Immunometabolic alterations in lupus: where do they come from and where do we go from there?","volume":"78","author":"Ma","year":"2022","journal-title":"Curr. Opin. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2024.110235_bb0180","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s11306-015-0772-0","article-title":"Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin","volume":"11","author":"Perl","year":"2015","journal-title":"Metabolomics"},{"issue":"5","key":"10.1016\/j.clim.2024.110235_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104241","article-title":"Microbiota-mediated skewing of tryptophan catabolism modulates CD4 T cells in lupus-prone mice","volume":"25","author":"Brown","year":"2022","journal-title":"iScience"},{"issue":"7","key":"10.1016\/j.clim.2024.110235_bb0190","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.cell.2018.10.001","article-title":"Distinct regulation of Th17 and Th1 cell differentiation by glutaminase-dependent metabolism","volume":"175","author":"Johnson","year":"2018","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.clim.2024.110235_bb0195","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/art.41019","article-title":"Glutaminase 1 inhibition reduces glycolysis and ameliorates lupus-like disease in MRL\/lpr mice and experimental autoimmune encephalomyelitis","volume":"71","author":"Kono","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.clim.2024.110235_bb0200","first-page":"1","article-title":"Caution in studying and interpreting the lupus metabolome","volume":"22","author":"Zhang","year":"2020","journal-title":"Arthritis Res."},{"key":"10.1016\/j.clim.2024.110235_bb0205","article-title":"Metabolic disturbances associated with systemic lupus erythematosus","volume":"7","author":"Wu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2024.110235_bb0210","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1021\/acs.jproteome.8b00192","article-title":"NMR-based serum metabolomics reveals reprogramming of lipid dysregulation following cyclophosphamide-based induction therapy in lupus nephritis","volume":"17","author":"Guleria","year":"2018","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.clim.2024.110235_bb0215","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1177\/0961203320918011","article-title":"Nuclear magnetic resonance\u2013based targeted profiling of urinary acetate and citrate following cyclophosphamide therapy in patients with lupus nephritis","volume":"29","author":"Ganguly","year":"2020","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.clim.2024.110235_bb0220","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nrrheum.2017.43","article-title":"Immunometabolism in systemic lupus erythematosus","volume":"13","author":"Morel","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.clim.2024.110235_bb0225","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1530\/EJE-17-0109","article-title":"Cortisol-related metabolic alterations assessed by mass spectrometry assay in patients with Cushing\u2019s syndrome","volume":"177","author":"Di Dalmazi","year":"2017","journal-title":"Eur. J. Endocrinol."},{"issue":"10","key":"10.1016\/j.clim.2024.110235_bb0230","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/ndt\/gfw291","article-title":"Con: the use of calcineurin inhibitors in the treatment of lupus nephritis","volume":"31","author":"Fernandez Nieto","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.clim.2024.110235_bb0235","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.mce.2012.10.030","article-title":"The immunosuppressive agent\u2019s rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in human adipose tissue","volume":"365","author":"Pereira","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"issue":"4","key":"10.1016\/j.clim.2024.110235_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecl.2007.07.003","article-title":"Immunosuppressive agents: effects on glucose and lipid metabolism","volume":"36","author":"Subramanian","year":"2007","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"issue":"274","key":"10.1016\/j.clim.2024.110235_bb0245","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa0835","article-title":"Normalization of CD4+ T cell metabolism reverses lupus","volume":"7","author":"Yin","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.clim.2024.110235_bb0250","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/nm.4375","article-title":"D-mannose induces regulatory T cells and suppresses immunopathology","volume":"23","author":"Zhang","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2024.110235_bb0255","article-title":"Glycomedicine: the current state of the art","author":"Wang","year":"2023","journal-title":"Engineering"},{"issue":"2","key":"10.1016\/j.clim.2024.110235_bb0260","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1089\/omi.2019.0220","article-title":"Digging deeper into precision\/personalized medicine: cracking the sugar code, the third alphabet of life, and sociomateriality of the cell","volume":"24","author":"\u00d6zdemir","year":"2020","journal-title":"OMICS"},{"key":"10.1016\/j.clim.2024.110235_bb0265","first-page":"545","article-title":"The rapidly expanding nexus of immunoglobulin G N-glycomics, suboptimal health status, and precision medicine","volume":"112","author":"Russell","year":"2021","journal-title":"Exp. Suppl."},{"key":"10.1016\/j.clim.2024.110235_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-6493-2_1","article-title":"Ubiquitous importance of protein glycosylation","volume":"1503","author":"Kri\u0161ti\u0107","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"11","key":"10.1016\/j.clim.2024.110235_bb0275","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1002\/art.39273","article-title":"Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome","volume":"67","author":"Vu\u010dkovi\u0107","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"5","key":"10.1016\/j.clim.2024.110235_bb0280","doi-asserted-by":"crossref","first-page":"880","DOI":"10.14336\/AD.2017.1121","article-title":"Glycation damage: a possible hub for major pathophysiological disorders and aging","volume":"9","author":"Fournet","year":"2018","journal-title":"Aging Dis."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624003449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624003449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T01:21:12Z","timestamp":1738459272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661624003449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":56,"alternative-id":["S1521661624003449"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2024.110235","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted metabolomics combined with machine learning to identify and validate new biomarkers for early SLE diagnosis and disease activity","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2024.110235","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110235"}}